Isosorbide Dinitrate — Membership Pricing
Isosorbide Dinitrate is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Isosorbide Dinitrate Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $172.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Isosorbide Dinitrate
Isosorbide Dinitrate is a prescription medication. Ask your doctor if Isosorbide Dinitrate is right for you.
How to Check Isosorbide Dinitrate Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Isosorbide Dinitrate at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
What Isosorbide Dinitrate is approved for (FDA label)
Isosorbide dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Source: Read the full FDA label on DailyMed. Label effective date: July 31, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Isosorbide Dinitrate (FDA label)
Adverse reactions to isosorbide dinitrate are generally dose-related, and almost all of these reactions are the result of isosorbide dinitrate's activity as a vasodilator. Headache, which may be severe, is the most commonly reported side effect. Headache may be recurrent with each daily dose, especially at higher doses. Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur. Hypotension occurs infrequently, but in some patients it may be severe enough to warrant discontinuation of therapy. Syncope, crescendo angina, and rebound hypertension have been reported but are uncommon. Extremely rarely, ordinary doses of organic nitrates have caused methemoglobinemia in normal-seeming patients.
Source: FDA prescribing information (DailyMed). Set ID: 6df6a2fa-c56c-4eb6-a485-c16585420eb0. SPL document ID: 90d3efd1-9d17-4bee-967d-30d2d7ba597c. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Isosorbide Dinitrate (FDA label)
Isosorbide dinitrate is contraindicated in patients who are allergic to isosorbide dinitrate or any of its ingredients. Do not use isosorbide dinitrate in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), such as sildenafil, tadalafil, or vardenafil. Concomitant use can cause severe hypotension, syncope, or myocardial ischemia. Do not use isosorbide dinitrate in patients who are taking the soluble guanylate cyclase stimulator riociguat. Concomitant use can cause hypotension.
Source: FDA prescribing information (DailyMed). Set ID: 6df6a2fa-c56c-4eb6-a485-c16585420eb0. SPL document ID: 90d3efd1-9d17-4bee-967d-30d2d7ba597c. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Isosorbide Dinitrate (FDA label)
The vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators. Alcohol, in particular, has been found to exhibit additive effects of this variety. Concomitant use of isosorbide dinitrate with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS ). Concomitant use of isosorbide dinitrate with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS ).
Source: FDA prescribing information (DailyMed). Set ID: 6df6a2fa-c56c-4eb6-a485-c16585420eb0. SPL document ID: 90d3efd1-9d17-4bee-967d-30d2d7ba597c. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.